Kirsch; Reinhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kirsch; Reinhard.The latest application filed is for "sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application".

Company Profile

0.30.19

Kirsch; Reinhard - Paris FR
Kirsch; Reinhard - Hochstadt N/A DE
Kirsch; Reinhard - Frankfurt am Main DE
KIRSCH; Reinhard - Braunschweig DE
Kirsch; Reinhard - Brunswick DE
Kirsch; Reinhard - Eppstein DE
Kirsch; Reinhard - Niederjosbach Taunus DT
Kirsch; Reinhard - Hofheim Taunus DT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof Grant 9,452,164 - Alcouffe , et al. September 27, 2	2016-09-27
Bearing assembly Grant 9,291,014 - Derrer , et al. March 22, 2	2016-03-22
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application Grant 9,150,544 - Alet , et al. October 6, 2	2015-10-06
Sulphonylaminopyrrolidinone Derivatives, Their Preparation And Their Therapeutic Application App 20140329801 - Alet; Nathalie ; et al.	2014-11-06
Imidazopyridine Derivatives, Process For Preparation Thereof And Therapeutic Use Thereof App 20140243328 - ALCOUFFE; Chantal ; et al.	2014-08-28
Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof Grant 8,759,344 - Alcouffe , et al. June 24, 2	2014-06-24
Imidazopyridine Derivatives, Process For Preparation Thereof And Therapeutic Use Thereof App 20130116250 - Alcouffe; Chantal ; et al.	2013-05-09
Malonamide derivatives with antithrombotic activity Grant 8,143,242 - Steinhagen , et al. March 27, 2	2012-03-27
Bearing Assembly App 20100316322 - Derrer; Siegfried ; et al.	2010-12-16
Malonamide Derivatives With Antithrombotic Activity App 20100249101 - STEINHAGEN; Henning ; et al.	2010-09-30
Imino acid derivatives as inhibitors of matrix metalloproteinases Grant 7,772,270 - Schudok , et al. August 10, 2	2010-08-10
Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes Grant 7,741,491 - Petry , et al. June 22, 2	2010-06-22
Wind power plant Grant 7,481,620 - Kirsch , et al. January 27, 2	2009-01-27
Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof Grant 7,453,000 - Petry , et al. November 18, 2	2008-11-18
Diphenylamine-substituted Salicylthiazole Derivatives And Related Compounds As Phosphotyrosine Phosphatase 1b (ptb1b) Inhibitors For Using As Blood-sugar Decreasing Active Ingredients For Treating Diabetes App 20070191441 - Petry; Stefan ; et al.	2007-08-16
Substituted Oxazolobenzoisothiazole Dioxide Derivatives Method For Production And Use Thereof App 20070149511 - Petry; Stefan ; et al.	2007-06-28
Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases Grant 7,166,609 - Klingler , et al. January 23, 2	2007-01-23
Imino acid derivatives as inhibitors of matrix metalloproteinases App 20060252752 - Schudok; Manfred ; et al.	2006-11-09
Wind power plant App 20060182634 - Kirsch; Reinhard ; et al.	2006-08-17
Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases Grant 6,933,298 - Weithmann , et al. August 23, 2	2005-08-23
Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives Grant 6,897,198 - Frick , et al. May 24, 2	2005-05-24
Imino acid derivatives as inhibitors of matrix metalloproteinases App 20050004166 - Schudok, Manfred ; et al.	2005-01-06
Selective MMP-13 inhibitors App 20050004111 - Klingler, Otmar ; et al.	2005-01-06
Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases App 20040167120 - Klingler, Otmar ; et al.	2004-08-26
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase Grant 6,716,853 - Stahl , et al. April 6, 2	2004-04-06
Pyridine-2,4-dicarboxylic Acid Diamides And Pyrimidine-4,6-dicarboxylic Acid Diamides And The Use Thereof For Selectively Inhibiting Collagenases App 20030229103 - Weithmann , Klaus-Ulrich ; et al.	2003-12-11
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase App 20030199543 - Stahl, Petra ; et al.	2003-10-23
Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives App 20030195145 - Frick, Wendelin ; et al.	2003-10-16
Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia Grant 6,632,838 - Kirsch , et al. October 14, 2	2003-10-14
Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives, process for their preparation, pharmaceuticals comprising these compounds and their use Grant 6,596,728 - Kirsch , et al. July 22, 2	2003-07-22
Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use Grant 6,569,835 - Frick , et al. May 27, 2	2003-05-27
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use Grant 6,566,340 - Frick , et al. May 20, 2	2003-05-20
Combinations with statin and aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use App 20020177610 - Frick, Wendelin ; et al.	2002-11-28
Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals App 20020072520 - Kirsch, Reinhard ; et al.	2002-06-13
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use App 20020042381 - Frick, Wendelin ; et al.	2002-04-11
Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals Grant 6,342,512 - Kirsch , et al. January 29, 2	2002-01-29
Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use Grant 6,303,639 - Frick , et al. October 16, 2	2001-10-16
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use Grant 6,245,744 - Frick , et al. June 12, 2	2001-06-12
Substituted quinoline derivatives with antiviral action Grant 6,114,349 - Kirsch , et al. September 5, 2	2000-09-05
Substituted quinoline derivatives, a process for their preparation, and their use Grant 5,798,365 - Kirsch , et al. August 25, 1	1998-08-25
Quinoxalines, a process for their preparation and their use Grant 5,723,461 - Rosner , et al. March 3, 1	1998-03-03
Substituted phenylsulfonyloxybenzimidazolecarbamates and anthelmintic compositions Grant 4,639,463 - Rosner , et al. January 27, 1	1987-01-27
Anthelmintically active basically substituted 2-carbalkoxy-amino-benzimidazolyl-5(6)-phenyl ethers and -ketones Grant 4,010,272 - Loewe , et al. March 1, 1	1977-03-01
Substituted triazino-benzimidazoles Grant 3,997,534 - Rochling , et al. December 14, 1	1976-12-14
Anthelmintically active 2-carbalkoxy-amino-benzimidazole-5(6)-phenyl ethers Grant 3,954,791 - Loewe , et al. May 4, 1	1976-05-04
Anthelmintically active 2-carbalkoxy-amino-benzimidazolyl-5(6)-amino-phenyl ethers Grant 3,928,375 - Duwel , et al. December 23, 1	1975-12-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.